Cytek Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cytek Biosciences generated cash of $5,281,000, which is more than the previous year. Cash used in financing activities reached the amount of -$41,812,000 last year. Net change in cash is therefore -$131,870,000.
Cash Flow
| 2019 | -13.74M | -973K | 93K |
|---|---|---|---|
| 2020 | 15.15M | -1.54M | 122.60M |
| 2021 | 4.63M | -20.99M | 213.55M |
| 2022 | -12.23M | -55.90M | 5.51M |
| 2023 | 5.28M | -93.89M | -41.81M |
CTKB Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 299.5M | 364.61M | 166.11M | 30.49M | 45.15M |
Operating activities | |||||
Net income | -12.14M | 2.48M | 3.02M | 19.41M | -16.82M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 9.23M | 5.65M | 1.24M | 603K | 309K |
Stock-based compensation expense | 22.04M | 16.59M | 6.58M | 611K | 269K |
| Deferred income tax benefit | 22.04M | 16.59M | 6.58M | 611K | 269K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -7.33M | -19.74M | -12.36M | 334K | -12.61M |
Inventories | 4.28M | -17.65M | -7.06M | -5.70M | -14.61M |
Accounts payable | -1.78M | 1.86M | -256K | -55K | 1.21M |
Cash generated by operating activities | 5.28M | -12.23M | 4.63M | 15.15M | -13.74M |
Investing activities | |||||
Purchases Of Investments | -175.93M | -46.04M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4.64M | -9.86M | -4.36M | -1.54M | -973K |
Acquisitions Net | -45.13M | 0 | -16.62M | 0 | 0 |
Cash generated by investing activities | -93.89M | -55.90M | -20.99M | -1.54M | -973K |
Financing activities | |||||
Common Stock Issued | 0 | 1.20M | 215.68M | 119.83M | 93K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -44.15M | -209K | 0 | 0 | 0 |
Repayments of term debt | -565K | 2.93M | -2.77M | -1.31M | 0 |
Cash used in financing activities | -41.81M | 5.51M | 213.55M | 122.60M | 93K |
Net Change In Cash | -131.87M | -65.11M | 198.49M | 135.62M | -14.66M |
Cash at end of period | 167.63M | 299.5M | 364.61M | 166.11M | 30.49M |
| Data source | Data source | Data source |